banner

Posts tagged as: Axesstel news back to homepage

Axesstel Revenue Dips in Third Quarter as Net Profit Increases Axesstel Revenue Dips in Third Quarter as Net Profit Increases(0)

Axesstel Inc. (OTCQB: AXST) Tuesday reported its earnings for the third quarter and nine months ended September 30.  Revenue for the quarter totaled $16.3 million; down from $17.1 million in the same quarter of 2011 for the provider of fixed wireless voice and broadband access solutions.  Net income significantly increased from $1.3 million, or 5 cents per diluted share, in Q3 2011 to $2.1 million, or 8 cents per diluted share, in the most recent quarter, due Read More

OTCBB News

Electronic Control Security Lands Prime Government Contract Electronic Control Security Lands Prime Government Contract(0)
Balqon Lithium Battery System Installed in Hybrid Yacht Balqon Lithium Battery System Installed in Hybrid Yacht(0)
Ecosphere Delivers Two More Ozonix Water Treatment Units to Hydrozonix Ecosphere Delivers Two More Ozonix Water Treatment Units to Hydrozonix(0)
ALR Technologies Names Former Pfizer Exec as Chief Commercial Officer ALR Technologies Names Former Pfizer Exec as Chief Commercial Officer(0)
Cellceutix Enters $10 Million Share Purchase Agreement, Shares Jump Cellceutix Enters $10 Million Share Purchase Agreement, Shares Jump(0)
Drinks Americas Signs Sales Agreement for Marigold Craft Beer Drinks Americas Signs Sales Agreement for Marigold Craft Beer(0)
read more


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.